Royal Bank Of Canada Organovo Holdings, Inc. Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.44 - $3.2 $5 - $12	4 New	4 $0
Q3 2022 Nov 14, 2022	SELL	$1.76 - $3.55 $3,122 - $6,297	-1,774 Reduced 93.17%	130 $0
Q2 2022 Aug 15, 2022	BUY	$1.71 - $3.71 $2,742 - $5,950	1,604 Added 534.67%	1,904 $3,000
Q1 2022 May 16, 2022	SELL	$2.74 - $4.41 $10 - $17	-4 Reduced 1.32%	300 $1,000
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.86 $911 - $1,721	251 Added 473.58%	304 $1,000
Q3 2021 Nov 15, 2021	SELL	$6.08 - $8.92 $285 - $419	-47 Reduced 47.0%	53 $0
Q2 2021 Aug 16, 2021	BUY	$6.65 - $9.95 $665 - $994	100 New	100 $1,000

2.51M

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $3.92M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.